AAV virus

Latest results from MTM gene therapy trial

Audentes Therapeutics has provided an update on its ASPIRO gene therapy trial. The study is evaluating AT132 in young children with X-linked myotubular myopathy.

Read more
Keep in touch
X
- Enter Your Location -
- or -